Biotech Company Working on COVID-19 Vaccine Announces Addition of 400 Jobs
A Gaithersburg company currently working on a COVID-19 vaccine announced it is expanding and expects to add 400 new jobs by the end of 2024, with most of the new… Read More
A Gaithersburg company currently working on a COVID-19 vaccine announced it is expanding and expects to add 400 new jobs by the end of 2024, with most of the new… Read More
On Thursday, Gov. Larry Hogan toured Novavax, a Gaithersburg company that is developing a COVID-19 vaccine. The vaccine candidate is currently in Phase 2 of clinical trials in the U.S.,… Read More
La empresa de biotecnología de Gaithersburg, Novavax, anunció el lunes que llegó a un acuerdo para administrar a Canadá hasta 76 millones de dosis de la vacuna COVID-19 de Novavax.… Read More
Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine. In a statement the… Read More
The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials.… Read More
The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August… Read More
The Tokyo-based Fujifilm Diosynth Biotechnologies joined other companies Monday in helping Gaithersburg’s Novavax produce and distribute the first batch of a potential COVID-19 vaccine to be used in clinical trials. … Read More
The heat emergency continues and the county has opened several cooling centers. It’s Tuesday, July 21, and here are five things to know in Montgomery County. 1. Council in Virtual… Read More
The Federal government recently awarded Gaithersburg-based biotech company Novavax 1.6 billion in funding to develop and distribute 100 million COVID-19 vaccines as early as the end of this year. County… Read More
Novavax—a biotechnology company located in Gaithersburg—has been awarded $1.6 billion to accelerate the development of a potential COVID-19 vaccine. The company announced Tuesday that it has been selected to participate in… Read More
A vaccine development company headquartered in Gaithersburg is starting clinical trials for a potential COVID-19 vaccine. Novavax will administer the trials for vaccine candidate NVX‑CoV2373 in two phases, a statement… Read More
A local bio-technology company has found a coronavirus vaccine candidate, and the first in-human trial is expected to begin in May. Novavax, which is located in Gaithersburg, develops next-generation vaccines for… Read More